AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
SEQUENTIAL ADMINISTRATION OF PACLITAXEL AND DOXORUBICIN FOLLOWED BY CMF IN WOMEN WITH ADVANCED BREAST-CANCER
Authors: PAPADIMITRIOU C DIMOPOULOS M LAZARIS D AMPELA C LOUVROUFERTAKI A ATHANASSIADES P STAMATELOPOULOS S KERAMOPOULOS A
Citation: C. Papadimitriou et al., SEQUENTIAL ADMINISTRATION OF PACLITAXEL AND DOXORUBICIN FOLLOWED BY CMF IN WOMEN WITH ADVANCED BREAST-CANCER, European journal of cancer, 34, 1998, pp. 49-49
DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES
Authors: FOUNTZILAS G DIMOPOULOS M PAPADIMITRIOU C ARAVANTINOS G BRIASSOULIS E BAFALOUKOS D PAPAKOSTAS P PAVLIDIS N SKARLOS D
Citation: G. Fountzilas et al., DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES, Annals of oncology, 9, 1998, pp. 685-685
CHARACTERIZATION OF ELASTOMER COMPOUNDS BY THERMAL-ANALYSIS
Authors: GINICMARKOVIC M CHOUDHURY NR DIMOPOULOS M WILLIAMS DRG MATISONS J
Citation: M. Ginicmarkovic et al., CHARACTERIZATION OF ELASTOMER COMPOUNDS BY THERMAL-ANALYSIS, Thermochimica acta, 316(1), 1998, pp. 87-95
PROGNOSTIC VALUE OF CYTOGENETICS IN MULTIPLE-MYELOMA
Authors: SEONG C DELASALLE K HAYES K WEBER D DIMOPOULOS M SWANTKOWSKI J HUH Y GLASSMAN A CHAMPLIN R ALEXANIAN R
Citation: C. Seong et al., PROGNOSTIC VALUE OF CYTOGENETICS IN MULTIPLE-MYELOMA, British Journal of Haematology, 101(1), 1998, pp. 189-194
DOCETAXEL AND CISPLATIN (DC) COMBINATION CHEMOTHERAPY FOR METASTATIC UROTHELIAL CANCER
Authors: DIMOPOULOS M LOURAS G PANTAZOPOULOS D DELIVELIOTIS C CONSTANTINIDIS C PAPADIMITRIOU C PAPADIMITRIS C KYRIAKAKIS Z MITROPOULOS D GEORGOULIAS V
Citation: M. Dimopoulos et al., DOCETAXEL AND CISPLATIN (DC) COMBINATION CHEMOTHERAPY FOR METASTATIC UROTHELIAL CANCER, European journal of cancer, 33, 1997, pp. 145-145
PHASE-I TRIAL OF CYCLOSPORINE-INDUCED AUTOLOGOUS GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH MULTIPLE-MYELOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE
Authors: GIRALT S WEBER D COLOME M DIMOPOULOS M MEHRA R VANBESIEN K GAJEWSKI J ANDERSSON B KHOURI I PRZEPIORKA D VONWOLFF B DELASALLE K KORBLING M SEONG D ALEXANIAN R CHAMPLIN R
Citation: S. Giralt et al., PHASE-I TRIAL OF CYCLOSPORINE-INDUCED AUTOLOGOUS GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH MULTIPLE-MYELOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE, Journal of clinical oncology, 15(2), 1997, pp. 667-673
LIMITED PRIMARY THERAPY FOR MULTIPLE-MYELOMA FOLLOWED BY MAINTENANCE WITH ALPHA-INTERFERON OR DEXAMETHASONE
Authors: ALEXANIAN R WEBER D DIMOPOULOS M DELASALLE K
Citation: R. Alexanian et al., LIMITED PRIMARY THERAPY FOR MULTIPLE-MYELOMA FOLLOWED BY MAINTENANCE WITH ALPHA-INTERFERON OR DEXAMETHASONE, Blood, 90(10), 1997, pp. 1585-1585
ANTIMYOSIN SCINTIGRAPHY FOR DETECTION OF CARDIAC AMYLOIDOSIS
Authors: LEKAKIS J DIMOPOULOS M NANAS J PRASSOPOULOS V AGAPITOS N ALEXOPOULOS G PALAZIS L KOSTAMIS P STAMATELOPOULOS S MOULOPOULOS S
Citation: J. Lekakis et al., ANTIMYOSIN SCINTIGRAPHY FOR DETECTION OF CARDIAC AMYLOIDOSIS, The American journal of cardiology, 80(7), 1997, pp. 963
CLINICAL-EXPERIENCE WITH FLUDARABINE IN HEMATOONCOLOGY
Authors: KEATING MJ OBRIEN S MCLAUGHLIN P DIMOPOULOS M GANDHI V PLUNKETT W LERNER S KANTARJIAN H ESTEY E
Citation: Mj. Keating et al., CLINICAL-EXPERIENCE WITH FLUDARABINE IN HEMATOONCOLOGY, HEM CELL TH, 38, 1996, pp. 83-91
MYELOABLATIVE TREATMENT FOR MULTIPLE-MYELOMA
Authors: ALEXANIAN R WEBER D DELASALLE K DIMOPOULOS M GIRALT S CHAMPLIN R
Citation: R. Alexanian et al., MYELOABLATIVE TREATMENT FOR MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3602-3602
VAD-CYCLOSPORINE THERAPY FOR VAD-RESISTANT MULTIPLE-MYELOMA
Authors: WEBER D DIMOPOULOS M SINICROPE F ALEXANIAN R
Citation: D. Weber et al., VAD-CYCLOSPORINE THERAPY FOR VAD-RESISTANT MULTIPLE-MYELOMA, Leukemia & lymphoma, 19(1-2), 1995, pp. 159-163
A PHASE I-II STUDY OF HIGH-DOSE THIOTEPA, BUSULFAN AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS TRANSPLANTATION FOR MALIGNANT-LYMPHOMA
Authors: PRZEPIORKA D NATH R IPPOLITI C MEHRA R HAGEMEISTER F DIENER K DIMOPOULOS M GIRALT S KHOURI I SAMUELS B VANBESIEN K ANDERSSON B DEISSEROTH AB LUNA M CABANILLAS F CHAMPLIN R
Citation: D. Przepiorka et al., A PHASE I-II STUDY OF HIGH-DOSE THIOTEPA, BUSULFAN AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS TRANSPLANTATION FOR MALIGNANT-LYMPHOMA, Leukemia & lymphoma, 17(5-6), 1995, pp. 427-433
DOSING OF THIOTEPA FOR MYELOABLATIVE THERAPY
Authors: PRZEPIORKA D MADDEN T IPPOLITI C ESTROV Z DIMOPOULOS M
Citation: D. Przepiorka et al., DOSING OF THIOTEPA FOR MYELOABLATIVE THERAPY, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 155-160
HIGH-DOSE CHEMOTHERAPY WITH BEAC REGIMEN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR INTERMEDIATE GRADE AND IMMUNOBLASTIC LYMPHOMA - DURABLE COMPLETE REMISSIONS, BUT A HIGH-RATE OF REGIMEN-RELATED TOXICITY
Authors: VANBESIEN K TABOCOFF J RODRIGUEZ M ANDERSSON B MEHRA R PRZEPIORKA D DIMOPOULOS M GIRALT S SUKI S KHOURI I SPITZER G JAGANNATH S DICKE K LEMAISTRE CF DEISSEROTH A CABANILLAS F CHAMPLIN RE
Citation: K. Vanbesien et al., HIGH-DOSE CHEMOTHERAPY WITH BEAC REGIMEN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR INTERMEDIATE GRADE AND IMMUNOBLASTIC LYMPHOMA - DURABLE COMPLETE REMISSIONS, BUT A HIGH-RATE OF REGIMEN-RELATED TOXICITY, Bone marrow transplantation, 15(4), 1995, pp. 549-555
REARRANGEMENTS OF THE NPM GENE ARE SELECTIVELY BUT INFREQUENTLY ASSOCIATED WITH ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)
Authors: MCBRIDE JA LUTHRA RL SARRIS AH WAASDORP M DIMOPOULOS M YOUNES A DEISSEROTH A CABANILLAS F MORRIS S PUGH WC
Citation: Ja. Mcbride et al., REARRANGEMENTS OF THE NPM GENE ARE SELECTIVELY BUT INFREQUENTLY ASSOCIATED WITH ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL), Laboratory investigation, 72(1), 1995, pp. 116-116
PRIMARY LYMPHOMA OF THE PROSTATE - GOOD OUTCOME WITH DOXORUBICIN-BASED COMBINATION CHEMOTHERAPY
Authors: SARRIS A DIMOPOULOS M PUGH W CABANILLAS F
Citation: A. Sarris et al., PRIMARY LYMPHOMA OF THE PROSTATE - GOOD OUTCOME WITH DOXORUBICIN-BASED COMBINATION CHEMOTHERAPY, The Journal of urology, 153(6), 1995, pp. 1852-1854
THE EXPANDING ROLE OF FLUDARABINE IN HEMATOLOGIC MALIGNANCIES
Authors: KEATING MJ OBRIEN S ROBERTSON LE KANTARJIAN H DIMOPOULOS M MCLAUGHLIN P CABANILLAS F GREGOIRE V YINGYANG L GANDHI V ESTEY E PLUNKETT W
Citation: Mj. Keating et al., THE EXPANDING ROLE OF FLUDARABINE IN HEMATOLOGIC MALIGNANCIES, Leukemia & lymphoma, 14, 1994, pp. 11-16
THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FORMARROW TRANSPLANTATION - RISK-FACTORS FOR EARLY REGIMEN-RELATED TOXICITY
Authors: PRZEPIORKA D DIMOPOULOS M SMITH T IPPOLITI C DIENER K LUNA M CHAMPLIN RE
Citation: D. Przepiorka et al., THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FORMARROW TRANSPLANTATION - RISK-FACTORS FOR EARLY REGIMEN-RELATED TOXICITY, Annals of hematology, 68(4), 1994, pp. 183-188
ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Authors: GIRALT SA LEMAISTRE CF VRIESENDORP HM ANDERSSON BS DIMOPOULOS M GAJEWSKI J VANBESIEN K MEHRA R PRZEPIORKA D KHOURI I YAU J KANTARJIAN H DEISSEROTH AB CHAMPLIN RE
Citation: Sa. Giralt et al., ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 12(9), 1994, pp. 1923-1930
FLUDARABINE PHOSPHATE - A NEW ACTIVE AGENT IN HEMATOLOGIC MALIGNANCIES
Authors: KEATING MJ OBRIEN S PLUNKETT W ROBERTSON LE GANDHI V ESTEY E DIMOPOULOS M CABANILLAS F KEMENA A KANTARJIAN H
Citation: Mj. Keating et al., FLUDARABINE PHOSPHATE - A NEW ACTIVE AGENT IN HEMATOLOGIC MALIGNANCIES, Seminars in hematology, 31(1), 1994, pp. 28-39
DRUG-THERAPY - THE TREATMENT OF MULTIPLE-MYELOMA
Authors: ALEXANIAN R DIMOPOULOS M
Citation: R. Alexanian et M. Dimopoulos, DRUG-THERAPY - THE TREATMENT OF MULTIPLE-MYELOMA, The New England journal of medicine, 330(7), 1994, pp. 484-489
PROGNOSTIC-SIGNIFICANCE OF MAGNETIC-RESONANCE-IMAGING (MRI) IN ASYMPTOMATIC MULTIPLE-MYELOMA
Authors: DIMOPOULOS M MOULOPOULOS L SMITH T WEBER D DELASALLE K ALEXANIAN R
Citation: M. Dimopoulos et al., PROGNOSTIC-SIGNIFICANCE OF MAGNETIC-RESONANCE-IMAGING (MRI) IN ASYMPTOMATIC MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000174-10000174
PRIMARY PLASMA-CELL LEUKEMIA
Authors: PALUMBO A DIMOPOULOS M DELASALLE K ALEXANIAN R
Citation: A. Palumbo et al., PRIMARY PLASMA-CELL LEUKEMIA, Blood, 84(10), 1994, pp. 10000178-10000178
EARLY MYELOABLATIVE THERAPY FOR MULTIPLE-MYELOMA
Authors: ALEXANIAN R DIMOPOULOS M HESTER J DELASALLE K CHAMPLIN R
Citation: R. Alexanian et al., EARLY MYELOABLATIVE THERAPY FOR MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000182-10000182
PRIMARY THERAPY OF WALDENSTROM MACROGLOBULINEMIA (WM) WITH 2-CHLORODEOXYADENOSINE (2CDA)
Authors: DIMOPOULOS M WEBER D KANTARJIAN H CABANILLAS F KEATING M ALEXANIAN R
Citation: M. Dimopoulos et al., PRIMARY THERAPY OF WALDENSTROM MACROGLOBULINEMIA (WM) WITH 2-CHLORODEOXYADENOSINE (2CDA), Blood, 84(10), 1994, pp. 10000386-10000386
Risultati: 1-25 | 26-37